Trial Profile
GnRHa Combined With hCG and hMG for Treatment of Patients With Non-obstructive Azoospermia: A Single-center Prospective Study in China
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Chorionic gonadotropin (Primary) ; Goserelin (Primary) ; Urofollitropin (Primary)
- Indications Azoospermia
- Focus Therapeutic Use
- 21 Dec 2015 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017 as reported by ClinicalTrials.gov.
- 21 Dec 2015 Planned primary completion date changed from 1 Oct 2016 to 1 Dec 2017 as reported by ClinicalTrials.gov.
- 21 Dec 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.